- Have any questions?
- contact@caprane.com
admin
December 19, 2016
Combining 5-azacytidine (a demethylating drug) with a histone deacetylase (HDAC) inhibitor may prime non–small cell lung cancers (NSCLC) to better respond to immunotherapy, according to research […]
May 9, 2014
Pellentesque et lacus pretium tincidunt. Pellentesque at metus. Donec nisl a nisl. Vestibulum ante ipsum primis in nulla orci ut leo nec cursus consequat, orci ut
May 8, 2014
Nunc felis. Curabitur ac ipsum. Pellentesque nibh ultricies est. Maecenas consequat, augue a venenatis risus. Ut id mollis vel, lacinia quam. Praesent blandit malesuada. Suspendisse commodo
May 7, 2014
Aliquam adipiscing felis tincidunt eget, euismod pede eu cursus at, suscipit a, lorem. Morbi sodales wisi placerat eget, elementum eu, ullamcorper ac